{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Oral+alprazolam+1+mg", "query": { "intervention": "Oral alprazolam 1 mg" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 13, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Oral+alprazolam+1+mg&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-02T01:37:11.566Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03398083", "title": "Evaluation of the Effects of Cannabidiol (CBD) Compared to Delta-9-Tetrahydrocannabinol (THC) and Alprazolam", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cannabis Use Disorder" ], "interventions": [ { "name": "THC", "type": "DRUG" }, { "name": "Alprazolam", "type": "DRUG" }, { "name": "Placebo oral capsule", "type": "DRUG" }, { "name": "CBD", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute on Drug Abuse (NIDA)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 42, "start_date": "2017-12-04", "completion_date": "2018-05-30", "has_results": false, "last_update_posted_date": "2018-06-14", "last_synced_at": "2026-10-02T01:37:11.566Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03398083" }, { "nct_id": "NCT00635076", "title": "A Study to Assess the Long-term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Panic Disorder" ], "interventions": [ { "name": "placebo", "type": "OTHER" }, { "name": "alprazolam XR", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "13 Years to 17 Years" }, "enrollment_count": 3, "start_date": "2004-07", "completion_date": "2004-09", "has_results": false, "last_update_posted_date": "2021-01-28", "last_synced_at": "2026-10-02T01:37:11.566Z", "location_count": 3, "location_summary": "Eugene, Oregon • San Antonio, Texas • Middleton, Wisconsin", "locations": [ { "city": "Eugene", "state": "Oregon" }, { "city": "San Antonio", "state": "Texas" }, { "city": "Middleton", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT00635076" }, { "nct_id": "NCT04970342", "title": "Validation of the Drug Impaired Driving Scenario (DIDS) on the CRCDS-miniSim", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Driving Behavior", "Driving Under the Influence" ], "interventions": [ { "name": "Placebo (Lactose) Capsule", "type": "DRUG" }, { "name": "0.75 mg Alprazolam Capsule", "type": "DRUG" }, { "name": "Cannabis (6.18% THC / <0.025% CBD)", "type": "DRUG" }, { "name": "Cannabis (0%/ THC / 0% CBD)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Timothy L. Brown", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "19 Years to 45 Years" }, "enrollment_count": 13, "start_date": "2021-07-16", "completion_date": "2021-08-21", "has_results": true, "last_update_posted_date": "2023-07-25", "last_synced_at": "2026-10-02T01:37:11.566Z", "location_count": 1, "location_summary": "Iowa City, Iowa", "locations": [ { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT04970342" }, { "nct_id": "NCT07154147", "title": "Oral vs IV Sedation for Cataract Surgery in Older Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cataract Surgery", "Sedation", "Cognition Function", "Perioperative Care", "Older Adults" ], "interventions": [ { "name": "Alprazolam", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 20, "start_date": "2025-08-12", "completion_date": "2026-01-19", "has_results": false, "last_update_posted_date": "2026-04-27", "last_synced_at": "2026-10-02T01:37:11.566Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07154147" }, { "nct_id": "NCT00634790", "title": "A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Panic Disorder" ], "interventions": [ { "name": "alprazolam XR", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "13 Years to 17 Years" }, "enrollment_count": 49, "start_date": "2004-05", "completion_date": "2004-10", "has_results": false, "last_update_posted_date": "2021-01-28", "last_synced_at": "2026-10-02T01:37:11.566Z", "location_count": 47, "location_summary": "Little Rock, Alaska • Phoenix, Arizona • Scottsdale, Arizona + 43 more", "locations": [ { "city": "Little Rock", "state": "Alaska" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Burbank", "state": "California" }, { "city": "El Centro", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00634790" }, { "nct_id": "NCT00603980", "title": "Staccato Alprazolam Abuse Liability", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Abuse Liability of Staccato Alprazolam" ], "interventions": [ { "name": "Inhaled placebo + oral placebo", "type": "DRUG" }, { "name": "Inhaled alprazolam 0.5 mg", "type": "DRUG" }, { "name": "Inhaled alprazolam 1 mg", "type": "DRUG" }, { "name": "Inhaled alprazolam 2 mg", "type": "DRUG" }, { "name": "Oral alprazolam 1 mg", "type": "DRUG" }, { "name": "Oral alprazolam 2 mg", "type": "DRUG" }, { "name": "Oral alprazolam 4 m", "type": "DRUG" }, { "name": "Oral alprazolam 2 mg qualifying session", "type": "DRUG" }, { "name": "Oral placebo qualifying session", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nova Pneuma Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 31, "start_date": "2008-01", "completion_date": "2009-01", "has_results": true, "last_update_posted_date": "2026-04-22", "last_synced_at": "2026-10-02T01:37:11.566Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00603980" }, { "nct_id": "NCT00574639", "title": "Mechanisms of Hypoglycemia Associated Autonomic Dysfunction Question 2", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Type 1 Diabetes" ], "interventions": [ { "name": "Alprazolam", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Maryland, Baltimore", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 14, "start_date": "2007-07", "completion_date": "2016-06", "has_results": false, "last_update_posted_date": "2019-09-12", "last_synced_at": "2026-10-02T01:37:11.566Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00574639" }, { "nct_id": "NCT03220113", "title": "Treatment of Chronic Migraine Headaches.", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Chronic Migraine Without Aura, Intractable", "Migraine With Typical Aura", "Migraine Disorders" ], "interventions": [ { "name": "Dexamethasone, Lidocaine, Thiamine cohort", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Corona Doctors Medical Clinics, Inc.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "10 Years to 90 Years" }, "enrollment_count": 100, "start_date": "2017-07-01", "completion_date": "2019-07-01", "has_results": false, "last_update_posted_date": "2018-04-04", "last_synced_at": "2026-10-02T01:37:11.566Z", "location_count": 1, "location_summary": "Corona, California", "locations": [ { "city": "Corona", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03220113" }, { "nct_id": "NCT00635531", "title": "A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Panic Disorder" ], "interventions": [ { "name": "placebo", "type": "OTHER" }, { "name": "alprazolam XR", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "13 Years to 17 Years" }, "enrollment_count": 16, "start_date": "2004-04", "completion_date": "2004-09", "has_results": false, "last_update_posted_date": "2021-01-28", "last_synced_at": "2026-10-02T01:37:11.566Z", "location_count": 18, "location_summary": "Hialeah, Florida • Jacksonville, Florida • North Miami, Florida + 15 more", "locations": [ { "city": "Hialeah", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "North Miami", "state": "Florida" }, { "city": "Boise", "state": "Idaho" }, { "city": "Terre Haute", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00635531" }, { "nct_id": "NCT03286218", "title": "A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug Users", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Recreational Drug Use", "Prescription Drug Abuse (Not Dependent)" ], "interventions": [ { "name": "Lasmiditan", "type": "DRUG" }, { "name": "Alprazolam", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 96, "start_date": "2017-09-15", "completion_date": "2017-11-20", "has_results": true, "last_update_posted_date": "2020-01-10", "last_synced_at": "2026-10-02T01:37:11.566Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03286218" } ] }